Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 6436 AL 6450

Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice

Ba F, Martin WR.

Parkinsonism Relat Disord. 2015 Feb;21(2):87-94. doi: 10.1016/j.parkreldis.2014.11.007. Epub 2014 Nov 20.

Parenchymal imaging in movement disorders

Fernandes Rde C, Berg D.

Front Neurol Neurosci. 2015;36:71-82. doi: 10.1159/000366238. Epub 2014 Dec 22.

Stem cell reprogramming: basic implications and future perspective for movement disorders

Brändl B, Schneider SA, Loring JF, Hardy J, Gribbon P, Müller FJ.

Mov Disord. 2015 Mar;30(3):301-12. doi: 10.1002/mds.26113. Epub 2014 Dec 27.

TREM2 R47H variant and risk of essential tremor: a cross-sectional international multicenter study

Ortega-Cubero S, Lorenzo-Betancor O, Lorenzo E, Agúndez JA, Jiménez-Jiménez FJ, Ross OA, Wurster I, Mielke C, Lin JJ, Coria F, Clarimon J, Ezquerra M, Brighina L, Annesi G, Alonso-Navarro H, García-Martin E, Gironell A, Marti MJ, Yueh KC, Wszolek ZK, Sharma M, Berg D, Krüger R, Pastor MA, Pastor P.

Parkinsonism Relat Disord. 2015 Mar;21(3):306-9. doi: 10.1016/j.parkreldis.2014.12.010. Epub 2014 Dec 24.

Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes

Antonini A, Yegin A, Preda C, Bergmann L, Poewe W; GLORIA study investigators and coordinators.

Parkinsonism Relat Disord. 2015 Mar;21(3):231-5. doi: 10.1016/j.parkreldis.2014.12.012. Epub 2014 Dec 19.

Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's disease

Cai H, Liu G, Sun L, Ding J.

Transl Neurodegener. 2014 Dec 10;3:27. doi: 10.1186/2047-9158-3-27. eCollection 2014.

Palatal myoclonus: algorithm for management with botulinum toxin based on clinical disease characteristics

Sinclair CF, Gurey LE, Blitzer A.

Laryngoscope. 2014 May;124(5):1164-9. doi: 10.1002/lary.23485. Epub 2014 Mar 25.

Infantile spasms and hyperekplexia associated with isolated sulfite oxidase deficiency

Holder JL Jr, Agadi S, Reese W, Rehder C, Quach MM.

JAMA Neurol. 2014 Jun;71(6):782-4. doi: 10.1001/jamaneurol.2013.5083.

Genetic forms of epilepsies and other paroxysmal disorders

Olson HE, Poduri A, Pearl PL.

Semin Neurol. 2014 Jul;34(3):266-79. doi: 10.1055/s-0034-1386765. Epub 2014 Sep 5.

A Case of Hemiabdominal Myoclonus

Nociti V, Servidei S, Luigetti M, Iorio R, Lo Monaco M, Mirabella M, Frisullo G, Della Marca G.

Clin EEG Neurosci. 2015 Oct;46(4):331-4. doi: 10.1177/1550059414533950. Epub 2014 Oct 8.

Propriospinal myoclonus: clinical reappraisal and review of literature

van der Salm SM, Erro R, Cordivari C, Edwards MJ, Koelman JH, van den Ende T, Bhatia KP, van Rootselaar AF, Brown P, Tijssen MA.

Neurology. 2014 Nov 11;83(20):1862-70. doi: 10.1212/WNL.0000000000000982. Epub 2014 Oct 10.

Myorhythmia: phenomenology, etiology, and treatment

Baizabal-Carvallo JF, Cardoso F, Jankovic J.

Mov Disord. 2015 Feb;30(2):171-9. doi: 10.1002/mds.26093. Epub 2014 Dec 9.

Propriospinal myoclonus: The spectrum of clinical and neurophysiological phenotypes

Antelmi E, Provini F.

Sleep Med Rev. 2015 Aug;22:54-63. doi: 10.1016/j.smrv.2014.10.007. Epub 2014 Nov 6.

Stiff-person syndrome: insights into a complex autoimmune disorder

Baizabal-Carvallo JF, Jankovic J.

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):840-8. doi: 10.1136/jnnp-2014-309201. Epub 2014 Dec 15.

[Botulinum toxin in the management of spasticity in children]

Benrhouma H, Yacoubi J, Kraoua I, Klaa H, Ben Youssef-Turki I, Gouider-Khouja N.

Rev Neurol (Paris). 2014 Aug-Sep;170(8-9):541-7. doi: 10.1016/j.neurol.2014.05.004. Epub 2014 Jun 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias